UBA1 (Ubiquitin-Like Modifier Activating Enzyme 1, also known as UBE1; encoded by the [UBA1 gene](/genes/uba1)) is the primary E1 ubiquitin-activating enzyme in human cells. It catalyzes the first step of the ubiquitination cascade, making it the master initiator of the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system).
Overview
UBA1 is a 117 kDa monomeric enzyme that activates ubiquitin through an ATP-dependent mechanism, forming a thioester intermediate before transferring ubiquitin to E2 conjugating enzymes<sup>[1]</sup>. As one of only two E1 enzymes for ubiquitin in mammals (along with UBA6), UBA1 is responsible for the vast majority (~99%) of cellular ubiquitination<sup>[2]</sup>. Its central position in proteostasis makes UBA1 activity critical for neuronal health and a convergence point in neurodegenerative disease mechanisms. [@hershko1998]
UBA1 has a multi-domain architecture optimized for ubiquitin activation and transfer<sup>[1]</sup>:
...
UBA1 Protein (E1 Ubiquitin-Activating Enzyme)
Introduction
UBA1 (Ubiquitin-Like Modifier Activating Enzyme 1, also known as UBE1; encoded by the [UBA1 gene](/genes/uba1)) is the primary E1 ubiquitin-activating enzyme in human cells. It catalyzes the first step of the ubiquitination cascade, making it the master initiator of the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system).
Overview
UBA1 is a 117 kDa monomeric enzyme that activates ubiquitin through an ATP-dependent mechanism, forming a thioester intermediate before transferring ubiquitin to E2 conjugating enzymes<sup>[1]</sup>. As one of only two E1 enzymes for ubiquitin in mammals (along with UBA6), UBA1 is responsible for the vast majority (~99%) of cellular ubiquitination<sup>[2]</sup>. Its central position in proteostasis makes UBA1 activity critical for neuronal health and a convergence point in neurodegenerative disease mechanisms. [@hershko1998]
UBA1 can simultaneously hold two ubiquitin molecules: one as adenylate in the AAD and one as thioester on Cys632.
Function
E2 Enzyme Interactions
UBA1 charges approximately 30-35 E2 ubiquitin-conjugating enzymes<sup>[3]</sup>, including:
UBE2D family: General-purpose E2s for proteasomal targeting
UBE2N/UBE2V: K63-linked chain assembly for signaling
UBE2S: K11-linked chains for cell cycle regulation
UBE2K: Works with E3 ligases for neurodegenerative protein clearance
UBE2R1: SCF complex-associated E2
Neuronal Proteostasis
UBA1 is critical for maintaining proteostasis in [neurons](/entities/neurons)<sup>[4]</sup>:
Misfolded protein clearance: Initiates ubiquitin tagging for proteasomal degradation of aggregation-prone proteins ([tau](/proteins/tau), [α-synuclein](/proteins/alpha-synuclein), [TDP-43](/proteins/tdp-43))
Synaptic protein turnover: Ubiquitin-dependent degradation of synaptic proteins regulates plasticity
Mitophagy initiation: Ubiquitination of outer mitochondrial membrane proteins by [Parkin](/genes/prkn) requires UBA1-activated ubiquitin
ER quality control: ERAD pathway depends on UBA1 for retrotranslocation and degradation of ER-misfolded proteins
Role in Neurodegeneration
Age-Related UBA1 Decline
UBA1 activity decreases with aging, contributing to proteostasis collapse<sup>[4]</sup>:
30-50% reduction in UBA1 protein levels in aged rodent brains
Reduced ubiquitin conjugation capacity in aged neurons
Correlates with accumulation of ubiquitin-positive inclusions
May represent an upstream driver of age-related neurodegeneration
Disease-Specific Involvement
[Alzheimer's disease](/diseases/alzheimers-disease): Reduced UBA1 in AD [hippocampus](/brain-regions/hippocampus); impaired ubiquitination of [tau](/proteins/tau) contributes to tangle formation
[Parkinson's disease](/diseases/parkinsons-disease): [UPS](/mechanisms/ubiquitin-proteasome-system) overwhelmed by [α-synuclein](/proteins/alpha-synuclein) aggregates; UBA1 activity insufficient for clearance
Motor neuron disease: UBA1 loss-of-function causes X-linked infantile SMA; motor neurons are especially dependent on UPS
Polyglutamine diseases: Expanded polyQ proteins sequester UBA1 and ubiquitin, depleting the UPS pool
Protein Interactions
| Interactor | Type | Function | |-----------|------|----------| | Ubiquitin | Substrate | Activated by adenylation and thioester formation | | ~35 E2 enzymes | Downstream | Receive activated ubiquitin via transthiolation | | Ubiquitin-like proteins | Related | UBA1 is specific for ubiquitin (not SUMO, NEDD8, etc.) | | UBA6 | Paralog | The only other E1 for ubiquitin; handles ~1% of ubiquitination | | Proteasome | Functional | End effector of UBA1-initiated ubiquitination |
Clinical Significance
VEXAS Syndrome
Somatic mutations eliminating the cytoplasmic UBA1b isoform (M41T/V/L) cause VEXAS<sup>[5]</sup>:
Systemic autoinflammation from UPS failure in myeloid cells
Treatment: azacitidine, JAK inhibitors, HSCT
Some patients develop neurological involvement (CNS vasculitis)
Therapeutic Potential
UBA1 activators: Small molecules enhancing UBA1 activity could broadly improve proteostasis
Gene therapy: AAV-UBA1 for X-linked SMA
Downstream enhancement: Proteasome activators, [autophagy](/entities/autophagy) inducers as complementary approaches
[Unknown, Schulman BA & Harper JW, Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways (2009) (2009)](https://doi.org/10.1038/nrm2673)
[Unknown, Hershko A & Ciechanover A, The ubiquitin system (1998) (1998)](https://doi.org/10.1146/annurev.biochem.67.1.461)
[Unknown, Ye Y & Bhatt DG, Abundance of E1 ubiquitin-activating enzymes in the human genome (2012) (2012)](https://doi.org/10.1074/jbc.R700029200)
[Unknown, Groen EJN & Gillingwater TH, UBA1: at the crossroads of ubiquitin homeostasis and neurodegeneration (2015) (2015)](https://doi.org/10.1016/j.tins.2014.12.005)
[Beck DB et al., Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease (2020) (2020)](https://doi.org/10.1056/NEJMoa2026834)